Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

High dose rate brachytherapy for oral cancer.

Yamazaki H, Yoshida K, Yoshioka Y, Shimizutani K, Furukawa S, Koizumi M, Ogawa K.

J Radiat Res. 2013 Jan;54(1):1-17. doi: 10.1093/jrr/rrs103. Epub 2012 Nov 23. Review.

2.

A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.

Vargas C, Ghilezan M, Hollander M, Gustafson G, Korman H, Gonzalez J, Martinez A.

J Urol. 2005 Sep;174(3):882-7.

PMID:
16093980
3.

High dose rate versus low dose rate interstitial radiotherapy for carcinoma of the floor of mouth.

Inoue T, Inoue T, Yamazaki H, Koizumi M, Kagawa K, Yoshida K, Shiomi H, Imai A, Shimizutani K, Tanaka E, Nose T, Teshima T, Furukawa S, Fuchihata H.

Int J Radiat Oncol Biol Phys. 1998 Apr 1;41(1):53-8.

PMID:
9588917
4.

Role of interstitial PDR brachytherapy in the treatment of oral and oropharyngeal cancer. A single-institute experience of 236 patients.

Strnad V, Melzner W, Geiger M, Zenk J, Waldfahrer F, Lotter M, Ott O, Seeger A, Iro H, Sauer R.

Strahlenther Onkol. 2005 Dec;181(12):762-7.

PMID:
16362785
5.
6.

Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.

Erickson B, Eifel P, Moughan J, Rownd J, Iarocci T, Owen J.

Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1083-92. Epub 2005 Aug 15.

PMID:
16099599
7.

High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.

Petereit DG, Sarkaria JN, Potter DM, Schink JC.

Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1267-74.

PMID:
10613322
8.

High-dose versus low-dose rate brachytherapy in definitive radiotherapy of cervical cancer.

Kucera H, Pötter R, Knocke TH, Baldass M, Kucera E.

Wien Klin Wochenschr. 2001 Jan 15;113(1-2):58-62.

PMID:
11233470
9.

The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma.

Nag S, Cano ER, Demanes DJ, Puthawala AA, Vikram B; American Brachytherapy Society.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1190-8.

PMID:
11483328
10.

Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.

Pos FJ, Horenblas S, Lebesque J, Moonen L, Schneider C, Sminia P, Bartelink H.

Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):696-705.

PMID:
15183473
11.

High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.

Grills IS, Martinez AA, Hollander M, Huang R, Goldman K, Chen PY, Gustafson GS.

J Urol. 2004 Mar;171(3):1098-104.

PMID:
14767279
12.

Brachytherapy provides comparable outcomes and improved cost-effectiveness in the treatment of low/intermediate prostate cancer.

Shah C, Lanni TB Jr, Ghilezan MI, Gustafson GS, Marvin KS, Ye H, Vicini FA, Martinez AA.

Brachytherapy. 2012 Nov-Dec;11(6):441-5. doi: 10.1016/j.brachy.2012.04.002. Epub 2012 Jun 23.

PMID:
22728157
13.

Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.

Hepel JT, Syed AM, Puthawala A, Sharma A, Frankel P.

Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1444-50.

PMID:
16029806
14.

Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.

Ferrigno R, Nishimoto IN, Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Salvajoli JV.

Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1108-16.

PMID:
15990016
15.

Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.

Lertsanguansinchai P, Lertbutsayanukul C, Shotelersuk K, Khorprasert C, Rojpornpradit P, Chottetanaprasith T, Srisuthep A, Suriyapee S, Jumpangern C, Tresukosol D, Charoonsantikul C.

Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1424-31.

PMID:
15275728
16.

[Present and future in brachytherapy--from the discovery of radium to the 21st century].

Inoue T, Inoue T.

Gan To Kagaku Ryoho. 1999 Aug;26(9):1254-60. Review. Japanese.

PMID:
10478177
17.

High-dose-rate brachytherapy for vaginal cancer: learning from treatment complications.

Tyree WC, Cardenes H, Randall M, Papiez L.

Int J Gynecol Cancer. 2002 Jan-Feb;12(1):27-31.

PMID:
11860533
18.

High-dose-rate prostate brachytherapy: an excellent accelerated-hypofractionated treatment for favorable prostate cancer.

Martinez AA, Demanes J, Vargas C, Schour L, Ghilezan M, Gustafson GS.

Am J Clin Oncol. 2010 Oct;33(5):481-8. doi: 10.1097/COC.0b013e3181b9cd2f.

PMID:
19952715
19.

Long-term results (10 years) of intensive breast conserving therapy including a high-dose and large-volume interstitial brachytherapy boost (LDR/HDR) for T1/T2 breast cancer.

Resch A, Pötter R, Van Limbergen E, Biber E, Klein T, Fellner C, Handl-Zeller L, Langbauer G, Schürer-Waldheim H, Staffen A, Jakesz R, Kubista E, Lehr S, Seitz W.

Radiother Oncol. 2002 Apr;63(1):47-58.

PMID:
12065103
20.

Head and neck brachytherapy.

Mazeron JJ, Noël G, Simon JM.

Semin Radiat Oncol. 2002 Jan;12(1):95-108. Review.

PMID:
11813154

Supplemental Content

Support Center